Journal ArticleJ Appl Gerontol · April 28, 2025
Distress behaviors are common in residential care settings and contribute to staff burnout and poor quality of life for older adults. While nonpharmacologic interventions reduce distress behaviors, implementation in routine care remains challenging. Our st ...
Full textLink to itemCite
Journal ArticleJ Geriatr Oncol · March 2025
INTRODUCTION: Opioids and benzodiazepines are commonly prescribed for cancer symptoms. In combination, they can increase the risk of adverse events, particularly for older adults with multimorbidity, who represent most patients with cancer. We aimed to und ...
Full textLink to itemCite
ConferenceInnovation in Aging · December 31, 2024
AbstractMost older adults in the US have multimorbidity (2+ serious illnesses). Living with multimorbidity impacts patient quality of life, specifically managing the symptoms of multiple diseases and accompa ...
Full textCite
Journal ArticleJ Manag Care Spec Pharm · October 2024
BACKGROUND: Trastuzumab is an antihuman epidermal growth factor receptor 2 monoclonal antibody used to treat breast and other cancers. Trastuzumab biosimilars were approved in the United States beginning in 2017. Utilization information on these biosimilar ...
Full textLink to itemCite
Journal ArticleJ Pain Symptom Manage · June 2024
CONTEXT: Use of palliative care interventions in chronic obstructive pulmonary disease (COPD) has increased in recent years and inclusion criteria used to identify patients with COPD appropriate for palliative care vary widely. We evaluated the inclusion c ...
Full textLink to itemCite
Journal ArticleJ Pain Symptom Manage · June 2024
CONTEXT: Driven by concerns about care quality, patient experience, and national metrics, health systems are increasingly focusing on identifying risk factors for patients who are hospitalized in the last month of life. OBJECTIVE: To evaluate patient facto ...
Full textLink to itemCite
Journal ArticleJAMA · April 23, 2024
IMPORTANCE: Falls are reported by more than 14 million US adults aged 65 years or older annually and can result in substantial morbidity, mortality, and health care expenditures. OBSERVATIONS: Falls result from age-related physiologic changes compounded by ...
Full textLink to itemCite
Journal ArticleClin Gerontol · 2024
OBJECTIVES: This review examines health care team-focused interventions on managing persistent or recurrent distress behaviors among older adults in long-term residential or inpatient health care settings. METHODS: We searched interventions addressing heal ...
Full textLink to itemCite
Journal ArticleHepatol Commun · June 1, 2023
BACKGROUND: Symptom-focused trials are critically needed for patients with cirrhosis. However, this work would benefit from standard processes and validated measures. METHODS: A writing group was formed among hepatologists, nurses, palliative care provider ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Clin Oncol · March 10, 2023
PURPOSE: The COVID-19 pandemic-related disruptions in health care delivery might have affected end-of-life care in patients with cancer. We examined changes in place of death and hospice support for Medicaid and commercially insured patients during the pan ...
Full textLink to itemCite
Journal ArticleJ Med Econ · 2023
BACKGROUND: Real-world evidence is a valuable source of information in healthcare. This study describes the challenges and successes during algorithm development to identify cancer cohorts and multi-agent chemotherapy regimens from claims data to perform a ...
Full textLink to itemCite
Journal ArticleJ Oncol Pharm Pract · June 2022
BACKGROUND: Polypharmacy raises the risk of drug-drug interactions and adverse events among patients with cancer. Most polypharmacy research has focused on adults age 65 or older enrolled in Medicare insurance. To better inform pharmacy practice and cancer ...
Full textLink to itemCite
Journal ArticleAm J Hosp Palliat Care · August 2021
PURPOSE: Multimorbidity is associated with increased intensity of end-of-life healthcare. This association has been examined by number but not type of conditions. Our purpose was to understand how intensity of care is influenced by multimorbidity within sp ...
Full textLink to itemCite
Journal ArticleDrugs Real World Outcomes · June 2021
BACKGROUND: Data on short-acting recombinant granulocyte colony-stimulating factor (G-CSF) biosimilar utilization from claims data in the USA are limited. OBJECTIVE: To evaluate patient baseline characteristics and utilization patterns for short-acting G-C ...
Full textLink to itemCite
Journal ArticlePharmacol Res Perspect · February 2021
We report utilization patterns and characteristics of patients treated with biologic anti-inflammatory agents in a large commercially insured patient population in the United States. We identified adult (age ≥18 years) patients receiving biologic anti-infl ...
Full textLink to itemCite
ConferenceJournal of Clinical Oncology · December 1, 2018
65 Background: Polypharmacy, or the concurrent use of multiple medications, may expose patients to drug-drug interactions and excessive costs. There are limited data on polypharmacy for commercially insured older adults, primaril ...
Full textCite
Journal ArticleJ Pain Symptom Manage · November 2018
CONTEXT: Limited data exist regarding how depression diagnosed at different times relative to a cancer diagnosis may affect healthcare utilization at end of life (EOL). OBJECTIVES: To assess the relationship between depression and health care utilization a ...
Full textLink to itemCite
ConferenceJournal of Clinical Oncology · November 1, 2017
86 Background: National bodies have proposed a number of metrics to measure quality of care at the end of life (EOL). MACRA legislation allows clinics to select the metrics they report to CMS. The self-selection of reported metri ...
Full textCite
ConferenceJournal of Clinical Oncology · November 1, 2017
79 Background: Polypharmacy, defined as the concurrent use of multiple medications, may expose patients to drug-drug interactions and excessive medication costs. Patients with advanced cancer may benefit from medication discontin ...
Full textCite
ConferenceJournal of Clinical Oncology · March 10, 2017
29 Background: Cancer care costs are rising, creating concerns about affordability. As a result, delivery systems are creating alternative payment structures to lower costs while maintaining or improving quality. As cancer care d ...
Full textCite
ConferenceJournal of Clinical Oncology · October 9, 2016
184 Background: End-of-life (EOL) care for persons with hematologic malignancies is variable and often involves high-intensity services at death approaches, which may not reflect patient or family preferences. We characterized he ...
Full textCite